Ditropan XL

See also: Generic Ditropan

Ditropan XL is a brand name of oxybutynin, approved by the FDA in the following formulation(s):

DITROPAN XL (oxybutynin chloride - tablet, extended release; oral)

• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: December 16, 1998
  
  Strength(s): 10MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: June 22, 1999
  
  Strength(s): 15MG ^[RLD][AB]

Has a generic version of Ditropan XL been approved?

A generic version of Ditropan XL has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ditropan XL and have been approved by the FDA:

oxybutynin chloride tablet, extended release; oral

• 
  Manufacturer: IMPAX PHARMS
  
  Approval date: November 9, 2006
  
  Strength(s): 15MG ^[AB]


• 
  Manufacturer: IMPAX PHARMS
  
  Approval date: May 9, 2007
  
  Strength(s): 10MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: November 9, 2006
  
  Strength(s): 10MG ^[AB], 5MG ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: May 10, 2007
  
  Strength(s): 15MG ^[AB]


• 
  Manufacturer: OSMOTICA PHARM
  
  Approval date: February 4, 2009
  
  Strength(s): 10MG ^[AB], 15MG ^[AB], 5MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ditropan XL. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Dosage form comprising oxybutynin
  Patent 5,674,895
  Issued: October 7, 1997
  Inventor(s): Guittard; George V. & Jao; Francisco & Marks; Susan M. & Kidney; David J. & Gumucio; Fernando
  Assignee(s): Alza Corporation
  A composition comprising oxybutynin and a device comprising oxybutynin are disclosed for oxybutynin therapy.
  
  Patent expiration dates:
  
  
  • May 22, 2015
    
  
  
  
  • November 22, 2015
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Dosage form comprising oxybutynin
  Patent 5,840,754
  Issued: November 24, 1998
  Inventor(s): Guittard; George V. & Jao; Francisco & Marks; Susan M. & Kidney; David J. & Gumucio; Fernando
  Assignee(s): ALZA Corporation
  A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
  
  Patent expiration dates:
  
  
  • May 22, 2015
    
  
  
  
  • November 22, 2015
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Dosage form and method for treating incontinence
  Patent 5,912,268
  Issued: June 15, 1999
  Inventor(s): Guittard; George V. & Jao; Francisco & Marks; Susan M. & Kidney; David J. & Gumucio; Fernando E.
  Assignee(s): Alza Corporation
  A composition comprising oxybutynin, a device comprising oxybutynin, and a method for administering oxybutynin are disclosed for oxybutynin therapy.
  
  Patent expiration dates:
  
  
  • May 22, 2015
    
  
  
  
  • November 22, 2015
    
    ✓ 
    Pediatric exclusivity
  
  



• 
  Method for the management of incontinence
  Patent 6,262,115
  Issued: July 17, 2001
  Inventor(s): Guittard; George V. & Jao; Francisco & Marks; Susan M. & Kidney; David J. & Gumucio; Fernando E.
  Assignee(s): ALZA Coporation
  A composition and a dosage form are disclosed comprising oxybutynin alone/or accompanied by another drug indicated for therapy. A method is disclosed for administering oxybutynin alone/or accompanied by a different drug or for administering oxybutynin and a different drug according to a therapeutic program for the management of incontinence alone, and for other therapy.
  
  Patent expiration dates:
  
  
  • May 22, 2015
    
    ✓ 
    Patent use: MANAGEMENT OF INCONTINENCE, MGT OF HORMONE REPLACEMENT THERAPY, TREATMENT OF INVOLUNTARY INCONTINENCE, MGT OVERACTIVE BLADDER AND INCREASING COMPLIANCE IN SUCH PT
  
  
  
  • November 22, 2015
    
    ✓ 
    Patent use: MANAGEMENT OF INCONTINENCE, MGT OF HORMONE REPLACEMENT THERAPY, TREATMENT OF INVOLUNTARY INCONTINENCE, MGT OVERACTIVE BLADDER AND INCREASING COMPLIANCE IN SUCH PT
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Ditropan XL Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Ditropan XL Consumer Information (Cerner Multum)
• Ditropan XL Advanced Consumer Information (Micromedex)
• Oxybutynin Consumer Information (Drugs.com)
• Oxybutynin Consumer Information (Wolters Kluwer)
• Oxybutynin Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Oxybutynin Gel Consumer Information (Wolters Kluwer)
• Oxybutynin Syrup Consumer Information (Wolters Kluwer)
• Oxybutynin System Consumer Information (Wolters Kluwer)
• Oxybutynin Consumer Information (Cerner Multum)
• Oxybutynin topical Consumer Information (Cerner Multum)
• Oxybutynin transdermal Consumer Information (Cerner Multum)
• Oxybutynin Advanced Consumer Information (Micromedex)
• Oxybutynin Transdermal Advanced Consumer Information (Micromedex)
• Oxybutynin Chloride AHFS DI Monographs (ASHP)

Mercryl Lauryle

Mercryl Lauryle may be available in the countries listed below.

Ingredient matches for Mercryl Lauryle

Mercurobutol

Mercurobutol is reported as an ingredient of Mercryl Lauryle in the following countries:

• Tunisia

International Drug Name Search

Brek

Brek may be available in the countries listed below.

Ingredient matches for Brek

Alendronic Acid

Alendronic Acid sodium trihydrate (a derivative of Alendronic Acid) is reported as an ingredient of Brek in the following countries:

• Argentina

International Drug Name Search

Bleomicina Asofarma

Bleomicina Asofarma may be available in the countries listed below.

Ingredient matches for Bleomicina Asofarma

Bleomycin

Bleomycin sulfate (a derivative of Bleomycin) is reported as an ingredient of Bleomicina Asofarma in the following countries:

• Argentina

International Drug Name Search

Bioflogil

Bioflogil may be available in the countries listed below.

Ingredient matches for Bioflogil

Chondroitin Polysulfate

Chondroitin Polysulfate sodium salt (a derivative of Chondroitin Polysulfate) is reported as an ingredient of Bioflogil in the following countries:

• Argentina

International Drug Name Search

Valpress

Valpress may be available in the countries listed below.

Ingredient matches for Valpress

Valsartan

Valsartan is reported as an ingredient of Valpress in the following countries:

• Bangladesh

International Drug Name Search

Baycip

Baycip may be available in the countries listed below.

Ingredient matches for Baycip

Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Baycip in the following countries:

• Chile


• Spain

Ciprofloxacin lactate (a derivative of Ciprofloxacin) is reported as an ingredient of Baycip in the following countries:

• Chile

International Drug Name Search

Lamotrigin Hexal

Lamotrigin Hexal may be available in the countries listed below.

Ingredient matches for Lamotrigin Hexal

Lamotrigine

Lamotrigine is reported as an ingredient of Lamotrigin Hexal in the following countries:

• Austria


• Denmark


• Estonia


• Finland


• Germany


• Lithuania


• Luxembourg


• Sweden

International Drug Name Search

Acéfylline diphénhydramine

Acéfylline diphénhydramine may be available in the countries listed below.

Ingredient matches for Acéfylline diphénhydramine

Diphenhydramine

Acéfylline diphénhydramine (DCF) is known as Diphenhydramine in the US.

International Drug Name Search

Glossary

DCF	Dénomination Commune Française

Click for further information on drug naming conventions and International Nonproprietary Names.

Estreptomicina Normon

Estreptomicina Normon may be available in the countries listed below.

Ingredient matches for Estreptomicina Normon

Streptomycin

Streptomycin sulfate (a derivative of Streptomycin) is reported as an ingredient of Estreptomicina Normon in the following countries:

• Spain

International Drug Name Search

Mépacrine

Mépacrine may be available in the countries listed below.

Ingredient matches for Mépacrine

Mepacrine

Mépacrine (DCF) is also known as Mepacrine (Rec.INN)

International Drug Name Search

Glossary

DCF	Dénomination Commune Française
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Sitinir

Sitinir may be available in the countries listed below.

Ingredient matches for Sitinir

Loratadine

Loratadine is reported as an ingredient of Sitinir in the following countries:

• Mexico

International Drug Name Search

Bromazépam Merck

Bromazépam Merck may be available in the countries listed below.

Ingredient matches for Bromazépam Merck

Bromazepam

Bromazepam is reported as an ingredient of Bromazépam Merck in the following countries:

• Tunisia

International Drug Name Search

Bromazepam LPH

Bromazepam LPH may be available in the countries listed below.

Ingredient matches for Bromazepam LPH

Bromazepam

Bromazepam is reported as an ingredient of Bromazepam LPH in the following countries:

• Romania

International Drug Name Search

Bromazepam Teva

Bromazepam Teva may be available in the countries listed below.

Ingredient matches for Bromazepam Teva

Bromazepam

Bromazepam is reported as an ingredient of Bromazepam Teva in the following countries:

• Belgium


• Italy

International Drug Name Search

Benoxuric

Benoxuric may be available in the countries listed below.

Ingredient matches for Benoxuric

Allopurinol

Allopurinol is reported as an ingredient of Benoxuric in the following countries:

• Indonesia

International Drug Name Search